|
A new genetic
screening technique may help identify whether or not breast cancers
are aggressive and likely to spread, according to researchers
at the Netherlands Cancer Institute in Amsterdam.
The researchers
reported in the journal Nature that they used microarrays to study
25,000 genes from breast cancers removed from 78 women, and found
70 genes that correctly predicted whether the cancer would or
would not metastasize quickly to other parts of the body in 65
of the patients.
While the
test is not ready for routine use, researchers hope that by identifying
active genes, doctors may ultimately be able to better individualize
treatment options, sparing women who have less aggressive forms
of breast cancer unnecessary treatment..
"Using the
current predictive criteria, 70 percent to 91 percent of the patients
cured with surgery and radiotherapy would be unnecessarily advised
to receive adjuvant (additional) therapy," said Carlos Caldas
of Cambridge University in an accompanying article. "In contrast,
using molecular forecasting, only a quarter of those patients
would have been advised to undergo such treatment."
"If molecular
forecasting of the outcome of cancer is indeed possible, as this
work suggests, it is a significant advance on existing prognostic
methods," added Caldas.
Other
Sources: Nature
|